Literature DB >> 12783655

[Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy].

Wei-guo Xu1, Zhan Gao, Ben-da Fan.   

Abstract

OBJECTIVES: To evaluate the efficacy of the tuberculosis (TB) control project supported by WPRO/WHO in Jiangsu province, China, and to analyze the factors associated with relapse.
METHODS: All registered patients with smear positive pulmonary tuberculosis which were diagnosed and cured in the project, were examined for bacteriological relapse after 2 to 3 years. The relationships among relapse rate, bacterial load and the time of sputum negative conversion were analyzed by historical cohort study.
RESULTS: Fifty seven cases of 1,730 patients who were followed for 2 - 3 years were found smear positive, the relapse rate being 3.29%. The relapse rates in patients whose sputum became negative within two months, within three months and beyond three months after the start of therapy were 2.1%, 5.3% and 8.8% (P < 0.01), respectively.
CONCLUSIONS: The long-term result of the TB control project in Jiangsu was good. The relapse rates in patients whose sputum converted negative within three months and beyond three months after the start of therapy were significantly higher than that in patients whose sputum converted negative within two months.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12783655

Source DB:  PubMed          Journal:  Zhonghua Jie He He Hu Xi Za Zhi        ISSN: 1001-0939


  2 in total

1.  Differential expression of interleukin-4 (IL-4) and IL-4 delta 2 mRNA, but not transforming growth factor beta (TGF-beta), TGF-beta RII, Foxp3, gamma interferon, T-bet, or GATA-3 mRNA, in patients with fast and slow responses to antituberculosis treatment.

Authors:  Joel Fleury Djoba Siawaya; Nchinya Bennedict Bapela; Katharina Ronacher; Nulda Beyers; Paul van Helden; Gerhard Walzl
Journal:  Clin Vaccine Immunol       Date:  2008-06-25

2.  Prevalence of extended treatment in pulmonary tuberculosis patients receiving first-line therapy and its association with recurrent tuberculosis in Beijing, China.

Authors:  YinYin Xia; Sonu Goel; Anthony D Harries; ZhiGuo Zhang; TieJie Gao; LiXia Wang; ShiMing Cheng; Yan Lin; Xin Du
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-05-25       Impact factor: 2.184

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.